{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:06:56Z","timestamp":1791094016010,"version":"4.1.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.critrevonc.2010.12.003","type":"journal-article","created":{"date-parts":[[2011,1,27]],"date-time":"2011-01-27T04:35:24Z","timestamp":1296102924000},"page":"330-343","source":"Crossref","is-referenced-by-count":151,"title":["Lymphoblastic lymphoma"],"prefix":"10.1016","volume":"79","author":[{"given":"Sergio","family":"Cortelazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s J.M.","family":"Ferreri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Hoelzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2010.12.003_bib0005","series-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","first-page":"168","article-title":"B lymphoblastic leukaemia\/lymphoma, not otherwise specified","author":"Borowitz","year":"2008"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0010","series-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","first-page":"171","article-title":"B lymphoblastic leukaemia\/lymphoma, with recurrent genetic abnormalitis","author":"Borowitz","year":"2008"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0015","series-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","first-page":"176","article-title":"T lymphoblastic leukaemia\/lymphoma","author":"Borowitz","year":"2008"},{"issue":"Suppl. (3)","key":"10.1016\/j.critrevonc.2010.12.003_bib0020","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.3816\/CLM.2009.s.015","article-title":"T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity?","volume":"9","author":"Hoelzer","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/pbc.20550","article-title":"Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma","volume":"47","author":"Raetz","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0030","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ejca.2008.02.011","article-title":"Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial","volume":"44","author":"Uyttebroeck","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0035","first-page":"416","article-title":"Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report","volume":"95","author":"Reiter","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0040","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/sj.leu.2404156","article-title":"High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)","volume":"20","author":"Jabbour","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0045","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the international lymphoma classification of non-Hodgkin's lymphoma. The non-Hodgkin's lymphoma classification project","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0050","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","article-title":"Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995","volume":"92","author":"Groves","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0055","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2648::AID-CNCR22>3.0.CO;2-R","article-title":"B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology","volume":"85","author":"Soslow","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0060","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10552-008-9147-4","article-title":"Lymphoma survival patterns by WHO subtype in the United States, 1973\u20132003","volume":"19","author":"Han","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992\u20132001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0070","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(97)09028-4","article-title":"Spectrum of AIDS-associated malignant disorders","volume":"351","author":"Goedert","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0075","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/aje\/kwi341","article-title":"Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case\u2013control study","volume":"162","author":"Engels","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0080","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","volume":"111","author":"Ekstrom","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0085","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1034\/j.1600-6143.2002.21019.x","article-title":"Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk","volume":"2","author":"Dharnidharka","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0090","first-page":"300","article-title":"Lymphoid malignancies in Nebraska: a hypothesis","volume":"70","author":"Weisenburger","year":"1985","journal-title":"Nebraska Med J"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0095","first-page":"2447","article-title":"Pesticides and other agricultural risk factors for non-Hodgkin's lymphoma among men in Iowa and Minnesota","volume":"52","author":"Cantor","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.leukres.2009.07.023","article-title":"Expression and prognostic significance of the apoptotic genes BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic leukemia","volume":"34","author":"Yang","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0105","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1126\/science.1182378","article-title":"The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal","volume":"327","author":"McCormack","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1182\/asheducation-2009.1.353","article-title":"The role of NOTCH1 signaling in T-ALL. Hematology","author":"Ferrando","year":"2009","journal-title":"Am Soc Hematol Educ Program"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0115","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/gcc.20736","article-title":"Cytogenetics of long-term survivors of ETV6-RUNX1 fusion positive acute lymphoblastic leukemia","volume":"49","author":"Konn","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0120","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/(SICI)1096-9896(1998100)186:2<140::AID-PATH149>3.0.CO;2-Y","article-title":"Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma","volume":"186","author":"Pilozzi","year":"1998","journal-title":"J Pathol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0125","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1182\/blood-2006-08-039024","article-title":"The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas","volume":"109","author":"Natkunam","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0130","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/modpathol.3800694","article-title":"Differential expression of the novel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia","volume":"19","author":"Cui","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0135","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1309\/AJCPZ7E9IMXVSNPT","article-title":"Acute lymphoblastic leukemia with Burkitt-like morphologic features and high myeloperoxidase activity","volume":"132","author":"Rytting","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0140","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood.V57.6.1105.1105","article-title":"Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma","volume":"57","author":"Bernard","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0145","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/00000478-199211000-00006","article-title":"Prethymic adult lymphoblastic lymphoma. A clinicopathologic and immunohistochemical analysis","volume":"16","author":"Quintanilla-Martinez","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0150","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00000478-199702000-00016","article-title":"Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity","volume":"21","author":"Koita","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0155","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1182\/blood.V89.12.4665","article-title":"Acute lymphoblastic leukemia\/lymphoblastic lymphoma of natural killer (NK) lineage: quest for another NK-lineage neoplasm","volume":"89","author":"Nakamura","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0160","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1542\/peds.100.1.60","article-title":"Cutaneous involvement in children with acute lymphoblastic leukemia or lymphoblastic lymphoma. The Children's Leukemia Cooperative Group of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"100","author":"Millot","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0165","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1309\/Q5GV-3K00-WAC6-BBUB","article-title":"Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature","volume":"115","author":"Maitra","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0170","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0161-5890(97)00031-X","article-title":"Immunoglobulin VH gene replacements in a T-cell lymphoblastic lymphoma","volume":"34","author":"Rosenquist","year":"1997","journal-title":"Mol Immunol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0175","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1182\/blood.V93.12.4079","article-title":"Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage","volume":"93","author":"Szczepanski","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0889-8588(05)70200-8","article-title":"Lymphoblastic lymphoma","volume":"15","author":"Thomas","year":"2001","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2006.07.011","article-title":"Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08","volume":"172","author":"Lones","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0190","first-page":"672","article-title":"Clinical characteristics of infant acute leukemia with or without 11q23 translocations","volume":"2","author":"Kaneko","year":"1988","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0195","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00000478-199203000-00003","article-title":"T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy","volume":"16","author":"Abruzzo","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0200","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood.V85.7.1881.bloodjournal8571881","article-title":"A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia\/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity","volume":"85","author":"Inhorn","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0205","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1038\/sj.leu.2401558","article-title":"Therapy-related T cell lymphoblastic lymphoma with t(11;19)(q23;p13) and MLL gene rearrangement","volume":"13","author":"Thandla","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0210","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/sj.leu.2404662","article-title":"Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma","volume":"21","author":"Metzgeroth","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0215","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/0277-5379(88)90053-3","article-title":"Lymphoblastic lymphoma in adults: a clinicopathological study of 34 cases treated at the Institut Gustave-Roussy","volume":"24","author":"Salloum","year":"1988","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0220","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/archderm.144.9.1155","article-title":"Cutaneous precursor B-cell lymphoblastic lymphoma in 2 adult patients: clinicopathologic and molecular cytogenetic studies with a review of the literature","volume":"144","author":"Shafer","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0225","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0046-8177(97)90254-9","article-title":"MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma\/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities","volume":"28","author":"Soslow","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0230","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1182\/blood-2002-01-0110","article-title":"Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia","volume":"99","author":"Hoelzer","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0235","first-page":"1391a","article-title":"LBL: results of a prospective treatment trial (BMFT study)","volume":"93","author":"Engelhard","year":"1996","journal-title":"Br J Heatol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0240","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1002\/1097-0142(19810515)47:10<2510::AID-CNCR2820471034>3.0.CO;2-8","article-title":"Lymphoblastic lymphoma in adults","volume":"47","author":"Streuli","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0245","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood.V85.5.1151.bloodjournal8551151","article-title":"The biology and treatment of acute lymphoblastic leukemia in adults","volume":"85","author":"Copelan","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0250","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/cncr.22807","volume":"110","author":"Tsukamoto","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0255","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1200\/JCO.1989.7.2.186","article-title":"Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution","volume":"7","author":"Murphy","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0260","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1200\/JCO.1986.4.11.1628","article-title":"Treatment of lymphoblastic lymphoma in adults","volume":"4","author":"Coleman","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0265","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1182\/blood-2008-11-185132","article-title":"Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)","volume":"113","author":"Bassan","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0270","first-page":"3564","article-title":"A novel approach for minimal residual disease detection in childhood T-cell lymphoblastic lymphoma (T-LL): a children's oncology group report","volume":"110","author":"Coustan-Smith","year":"2007","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0275","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/1096-911X(200007)35:1<20::AID-MPO4>3.0.CO;2-L","article-title":"Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90","volume":"35","author":"Neth","year":"2000","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0280","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1182\/blood-2003-12-4428","article-title":"Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma","volume":"104","author":"Thomas","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0285","first-page":"305","article-title":"A phase II study on intensive ALL-type chemotherapy with minimal residual disease (MRD) oriented postremission strategy in adult patients wiyth LBL (protocol NILG-ALL 09\/00)","volume":"s1","author":"Cortelazzo","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0290","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/pbc.22162","article-title":"Long-term results of AIEOP LNH-92 protocol for the treatment of pediatric lymphoblastic lymphoma: a report of the Italian Association of Pediatric Hematology and Oncology","volume":"53","author":"Pillon","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0295","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1200\/JCO.1993.11.6.1024","article-title":"Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group","volume":"11","author":"Anderson","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0300","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM199004263221701","article-title":"Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy","volume":"322","author":"Link","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0305","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1200\/JCO.2002.06.017","article-title":"Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report","volume":"20","author":"Lones","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0310","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1200\/JCO.1988.6.1.26","article-title":"Lymphoblastic lymphoma in children\u2014a randomized trial comparing LSA2-L2 with the A-COP+ therapeutic regimen: a Pediatric Oncology Group Study","volume":"6","author":"Hvizdala","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0315","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/mpo.2950200204","article-title":"Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma","volume":"20","author":"Patte","year":"1992","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0320","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/beha.2002.0230","article-title":"Treatment of lymphoblastic lymphoma in adults","volume":"15","author":"Hoelzer","year":"2002","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0325","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","author":"INHLPFP","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0330","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1200\/JCO.2001.19.11.2927","volume":"19","author":"Sweetenham","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0335","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJM198303103081003","article-title":"Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)","volume":"308","author":"Anderson","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0340","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1182\/blood.V66.5.1110.1110","article-title":"A novel treatment of childhood lymphoblastic non-Hodgkin's lymphoma: early and intermittent use of teniposide plus cytarabine","volume":"66","author":"Dahl","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0345","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.1983.1.9.537","article-title":"Long-term results of the APO protocol (vincristine, doxorubicin [adriamycin], and prednisone) for treatment of mediastinal lymphoblastic lymphoma","volume":"1","author":"Weinstein","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0350","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/1097-0142(197601)37:1<123::AID-CNCR2820370119>3.0.CO;2-7","article-title":"Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy","volume":"37","author":"Wollner","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0355","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1023\/A:1008202808144","article-title":"Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: a report on 62 patients from a single center","volume":"9","author":"Bouabdallah","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0360","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/oxfordjournals.annonc.a059214","article-title":"Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients","volume":"6","author":"Jost","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0365","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/sj.leu.2403095","article-title":"Adult lymphoblastic lymphoma: a retrospective analysis of 92 patients under 61 years included in the LNH87\/93 trials","volume":"17","author":"Le","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0370","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/cncr.11615","article-title":"Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center","volume":"98","author":"Mora","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0375","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1200\/JCO.1986.4.1.57","article-title":"Lymphoblastic lymphoma in adults","volume":"4","author":"Slater","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0380","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1200\/JCO.1992.10.7.1078","article-title":"Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients","volume":"10","author":"Morel","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0385","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/10428199609054867","article-title":"Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients","volume":"23","author":"Zinzani","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0390","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01834382","article-title":"High-dose Ara-C for remission induction and consolidation of previously untreated adults with ALL or lymphoblastic lymphoma","volume":"70","author":"Willemze","year":"1995","journal-title":"Ann Hematol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0395","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.leu.2401310","article-title":"Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study","volume":"13","author":"Amylon","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0400","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/cncr.21901","article-title":"Activity of alemtuzumab in patients with CD52-positive acute leukemia","volume":"106","author":"Tibes","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0405","first-page":"322","article-title":"The sensitivity of acute lymphoblastic leukemia cells carrying the t(12;21) translocation to campath-1H-mediated cell lysis","volume":"91","author":"Golay","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0410","first-page":"1135","article-title":"Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma","volume":"3","author":"Cooper","year":"2007","journal-title":"Ther Clin Risk Manage"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0415","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1182\/blood-2006-11-056754","article-title":"Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801","volume":"109","author":"DeAngelo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0420","first-page":"3957","article-title":"Young adults with acute lymphoblastic leukemia (ALL) treated with adapted augmented Berlin\u2013Frankfurt\u2013Munster (ABFM) therapy","volume":"112","author":"Rytting","year":"2008","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"issue":"Suppl. (2)","key":"10.1016\/j.critrevonc.2010.12.003_bib0425","first-page":"195","article-title":"Immunochemotherapy with rituzimab in adult CD20+ B-precursor all improves molecular CR rate and outcome in standard risk (SR) as well as in high rish (HR) patients with SCT","volume":"94","author":"Hoelzer","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0430","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.bmt.1705425","article-title":"Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia","volume":"38","author":"Kebriaei","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0435","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1365-2141.2008.07497.x","article-title":"Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy","volume":"144","author":"Jaime-Perez","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0440","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/oxfordjournals.annonc.a058107","article-title":"Adult lymphoblastic lymphoma: high incidence of central nervous system relapse in patients treated with the Stanford University protocol","volume":"3","author":"Sweetenham","year":"1992","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0445","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/mpo.10055","article-title":"CNS late-effects after ALL therapy in childhood, Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory","volume":"38","author":"Langer","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0450","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1200\/JCO.2003.04.089","article-title":"Impact of CNS treatment on mood in adult survivors of childhood leukemia: a report from the Children's Cancer Group","volume":"21","author":"Glover","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0455","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/pbc.20334","article-title":"Reduction of adult height in childhood acute lymphoblastic leukemia survivors after prophylactic cranial irradiation","volume":"45","author":"Bongers","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0460","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.2005.02.2707","article-title":"Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma","volume":"24","author":"Burkhardt","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0465","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1200\/JCO.1993.11.7.1208","article-title":"Cardiac disease following treatment of Hodgkin's disease in children and adolescents","volume":"11","author":"Hancock","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0470","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199603213341201","article-title":"Breast cancer and other second neoplasms after childhood Hodgkin's disease","volume":"334","author":"Bhatia","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0475","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/bjc.1987.91","article-title":"Second malignancies in children treated for non-Hodgkin's lymphoma and T-cell leukaemia with the UKCCSG regimens","volume":"55","author":"Ingram","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0480","first-page":"33","article-title":"Autologous bone marrow transplantation in 22 adult patients with lymphoblastic lymphoma responsive to conventional dose chemotherapy","volume":"10","author":"Baro","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0485","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.1994.12.7.1358","article-title":"High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation","volume":"12","author":"Sweetenham","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0490","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.bbmt.2005.07.001","article-title":"Chemotherapy and hematopoietic stem cell transplantation for adult T-cell lymphoblastic lymphoma: current status and controversies","volume":"11","author":"Aljurf","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0495","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1200\/JCO.1992.10.4.644","article-title":"Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission","volume":"10","author":"Verdonck","year":"1992","journal-title":"J Clin Oncol"},{"issue":"Suppl (1)","key":"10.1016\/j.critrevonc.2010.12.003_bib0500","first-page":"42","article-title":"Autologous bone marrow transplantation for adult advanced stage lymphoblastic lymphoma in first CR. a study of the NHLCSG","volume":"5","author":"Santini","year":"1991","journal-title":"Leukemia"},{"issue":"Suppl (1)","key":"10.1016\/j.critrevonc.2010.12.003_bib0505","first-page":"477a","article-title":"Autologous stem cell transplantation (ASCT) for LBL (LBL)","volume":"94","author":"Conde","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0510","first-page":"767","article-title":"Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission","volume":"14","author":"De Witte","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0515","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9343(97)89488-0","article-title":"Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology","volume":"100","author":"van Besien","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0520","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1182\/blood-2002-05-1483","article-title":"A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma","volume":"101","author":"Levine","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0525","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood.V81.8.2003.2003","article-title":"Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first line therapy: a report from the Societe Francaise d\u2019Oncologie Pediatrique","volume":"81","author":"Philip","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0530","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.0902-4441.2006.t01-1-EJH2889.x","article-title":"Treatment with bortezomib in a patient with heavily pretreated refractory T-cell lymphoblastic lymphoma","volume":"77","author":"Mai","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0535","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4161\/auto.5.5.8507","article-title":"RAD001 (Everolimus) induces autophagy in acute lymphoblastic leukemia","volume":"5","author":"Crazzolara","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0540","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1158\/0008-5472.CAN-08-4884","article-title":"Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia","volume":"69","author":"Chiarini","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0545","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10495-006-3392-3","article-title":"Curcumin induces apoptosis via inhibition of PI3\u2019-kinase\/AKT pathway in acute T cell leukemias","volume":"11","author":"Hussain","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0550","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1182\/blood-2008-02-136762","article-title":"Targeting the Notch1 and mTOR pathways in a mouse T-ALL model","volume":"113","author":"Cullion","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0555","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm1588","article-title":"Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia","volume":"13","author":"Medyouf","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.critrevonc.2010.12.003_bib0560","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.2174\/138161209788923949","article-title":"Recombinant immunotoxins for the treatment of chemoresistant hematologic malignancies","volume":"15","author":"Kreitman","year":"2009","journal-title":"Curr Pharm Des"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842810002830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842810002830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T10:00:57Z","timestamp":1712138457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842810002830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":112,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1040842810002830"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2010.12.003","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}